Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system.

Elizabeth D KantorKelli O'ConnellIsaac J ErgasEmily ValiceJanise M RohJenna BhimaniNarre HeonJennifer J GriggsJean LeeErin Ja BowlesDonna R RiveraTatjana KolevskaElisa V BanderaLawrence H Kushi

Published in: Breast cancer research and treatment (2023)

Results offer insight on factors associated with chemotherapy dosing for a common breast cancer regimen. Larger studies are required to evaluate relevance to other regimens, and further work will be needed to determine whether dose reductions impact outcomes in obese women.

Keyphrases

healthcare
locally advanced
breast cancer risk
adipose tissue
polycystic ovary syndrome
weight loss
pregnancy outcomes
chemotherapy induced
obese patients
case control
bariatric surgery
skeletal muscle
social media